Literature DB >> 22473595

Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?

K Hemminki1, M Bevier, J Sundquist, A Hemminki.   

Abstract

BACKGROUND: Cancer of unknown primary (CUP) is diagnosed at the metastatic stage. We aimed to identify hidden primary cancers in CUP patients by comparison with cancers in family members. We take use of the fact that the cause of death in CUP patients is often coded as the cancer in the organ of fatal metastasis. PATIENTS AND METHODS: Forty-one thousand five hundred and twenty-three CUP patients were identified in the Swedish Family-Cancer Database, and relative risks (RRs) were calculated for cancer in offspring when family members were diagnosed with CUP and died of the cancer diagnosed in offspring.
RESULTS: The RR for lung cancer in offspring was 1.85 when a family member was diagnosed with CUP and died of lung cancer. Significant familial associations were found for seven other cancers. Many familial associations were also significant when offspring CUP patients died of the cancer diagnosed in family members.
CONCLUSIONS: The cause of death after CUP diagnosis frequently matched the cancer found in a family member, suggesting that the CUP had originated in that tissue. The metastasis had probably undergone a phenotypic change, complicating pathological tissue assignment. These novel data suggest that some CUP cases are phenotypically modified primary cancers rather than cancers of unknown primaries.

Entities:  

Mesh:

Year:  2012        PMID: 22473595     DOI: 10.1093/annonc/mds063

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  12 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

2.  Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.

Authors:  Matias Riihimäki; Akseli Hemminki; Kristina Sundquist; Kari Hemminki
Journal:  BMC Cancer       Date:  2014-06-14       Impact factor: 4.430

3.  Location of metastases in cancer of unknown primary are not random and signal familial clustering.

Authors:  Kari Hemminki; Kristina Sundquist; Jan Sundquist; Akseli Hemminki; Jianguang Ji
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.379

4.  Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis.

Authors:  Inga Blunk; Hauke Thomsen; Norbert Reinsch; Manfred Mayer; Asta Försti; Jan Sundquist; Kristina Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

Review 5.  Cancer of Unknown Primary Site: Real Entity or Misdiagnosed Disease?

Authors:  Alaa T Alshareeda; Batla S Al-Sowayan; Reem R Alkharji; Sahar M Aldosari; Abdullah M Al Subayyil; Ayidah Alghuwainem
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

Review 6.  Cancer of Unknown Primary: Challenges and Progress in Clinical Management.

Authors:  Noemi Laprovitera; Mattia Riefolo; Elisa Ambrosini; Christiane Klec; Martin Pichler; Manuela Ferracin
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

7.  Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.

Authors:  Matias Riihimäki; Hauke Thomsen; Akseli Hemminki; Kristina Sundquist; Kari Hemminki
Journal:  BMC Cancer       Date:  2013-01-28       Impact factor: 4.430

8.  Germline genetics of cancer of unknown primary (CUP) and its specific subtypes.

Authors:  Kari Hemminki; Bowang Chen; Abhishek Kumar; Olle Melander; Jonas Manjer; Göran Hallmans; Ulrika Pettersson-Kymmer; Claes Ohlsson; Gunnar Folprecht; Harald Löffler; Alwin Krämer; Asta Försti
Journal:  Oncotarget       Date:  2016-04-19

9.  Familial risks of second primary cancers and mortality in ovarian cancer patients.

Authors:  Guoqiao Zheng; Subhayan Chattopadhyay; Asta Försti; Kristina Sundquist; Kari Hemminki
Journal:  Clin Epidemiol       Date:  2018-10-11       Impact factor: 4.790

10.  Prostate cancer survivors: Risk and mortality in second primary cancers.

Authors:  Subhayan Chattopadhyay; Guoqiao Zheng; Otto Hemminki; Asta Försti; Kristina Sundquist; Kari Hemminki
Journal:  Cancer Med       Date:  2018-10-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.